Criteria used by general practitioners in prescribing prokinetic or antisecretory drugs in patients with functional dyspepsia;Criterios de los médicos de atención primaria para la indicación de tratamiento con procinéticos o antisecretores en pacientes con dispepsia funcional

Revista Espanola de Enfermedades Digestivas

Volumn 93, Issue 5, 2001, Pages 281-292

  Mones J ^a   Guilera, M ^a   Artes M ^a   Lopez J S ^a   Guerrero, T ^a   Fillat, O ^a  

^a Pharma Research   (Spain)

Author keywords

Antisecretory drugs; Functional dyspepsia; Prokinetics

Indexed keywords

ALKALI; CISAPRIDE; CLEBOPRIDE; DOMPERIDONE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; OMEPRAZOLE; PANTOPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RANITIDINE; ROXATIDINE; STOMACH SECRETION INHIBITOR;

ADULT; ARTICLE; CHRONICITY; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DYSPEPSIA; EVALUATION; FEMALE; FUNCTIONAL DISEASE; GASTROESOPHAGEAL REFLUX; GENDER; GENERAL PRACTITIONER; HUMAN; MALE; MULTICENTER STUDY; OBSERVATION; PREDICTION; PRESCRIPTION; PROSPECTIVE STUDY; SATIETY; STOMACH MOTILITY; STOMACH ULCER; SYMPTOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DYSPEPSIA; FAMILY PRACTICE; FEMALE; GASTROINTESTINAL AGENTS; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; PROTON PUMPS;

EID: 0038976125     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Management of nonulcer dyspepsia
2. Dyspepsia and dyspepsia subgroups a population based study
3. Prevalence of symptoms of dyspepsia in the community
4. Dyspepsia in general practice
5. Challenges in managing dyspepsia in general practice
6. A Canadian physician survey of dyspepsia management
7. Prevalence and clinical spectrum of gastroesofageal reflux in the community
8. Evaluation of dyspepsia
9. Functional dyspepsia: A classification with guidelines of diagnosis and management
10. Irritable bowel syndrome in patients with dyspepsia: A community-based study in southern Europe
11. Functional gastroduodenal disorders
12. Empiric therapy versus diagnostict test in grastroesophjageal reflux disease. A medical decision analysis
13. Is gastric acid responsible for the pain in patients with essential dyspepsia?
14. Abnormal clearance of exogenous acid and increased acid sensibility of the proximal duodenum in dyspeptic patients
15. Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia
16. Impaired accommodation of proximal stomach to a meal in functional dyspepsia
17. Role of impaired gastric accomodation to a meal in functional dyspepsia
18. Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with ideopathic gastroparesis
19. Drug treatment of functional dyspepsia - A meta-analysis of randomized controlled clinical trials
20. Drug treatment of functional dyspepsia: A systematic analysis of trial methodology with recomendations for design of future trials
21. Gastric emptying and myoelectrical activity in children with non-ulcer dyspepsia. Effect of cisapride
22. Smoking, alcohol and analgesics in dyspepsia and among dyspepsia subgroups: Lack of association in a community
23. Gastrointestinal side-effects of NAIDs in the community
24. Prevention of peptic ulcer and dyspepsia symptoms with omeprazole in patients receiving continous non-steroidal anti- inflamatory drug therapy. A nordic multicenter study
25. Dispepsia y antiinflamatorios no esteroideos: No todo es úlcera
26. Gastrointestinal symptoms and health related qualty of life in patients with arthritis
27. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia
28. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia
29. Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosieve prepyloric changes. A randomized, double-blind, placebo-controlled trial
30. Dyspepsia: Incidence of nonulcer disease in a controlle trial of ranitidine in general practice
31. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial
32. Efficacy of cisapride in functional dyspepsia resistant to domperiodone or metoclopramide: A double-blind, placebo controlled study
33. Efficacy of cisapride therapy in functional dyspepsia
34. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study
35. Cisapride compared with ranitidine in the treatment of functional dyspepsia
36. Placebo-controlled trial of cisapride and nizatidine in unselected patient with functional dyspepsia
37. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia
38. Risk factors, co-medication and concomitant diseases: Their influence on the outcome of therapy with cisapride
39. Factors predicting response to omeprazole treatment in patients with functional dyspepsia
40. The management of acid-related dyspepsia in general practice: A comparison of an omeprazole versus an antacid-alginare/ranitidine management strategy
41. Today's therapy of functional gastrointestinal disorders. Does it help?
42. Tratamiento de la dispepsia funcional
43. La calidad de vida ¿Se puede medir realmente?